FDA requests new Flutiform trial: <a href="http://www.reuters.com/article/marketsNews/idINL994635620090609" rel="nofollow" target="_blank">http://www.reuters.com/article/marketsNews/idINL994635620090609</a> ABT has the US commercial rights to this asthma treatment licensed from SkyePharma.